Welcome to our dedicated page for Tenet Healthcare SEC filings (Ticker: THC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tenet Healthcare Corporation filings document the regulatory record of a healthcare services company with hospital operations, an ambulatory surgery platform and Conifer revenue cycle management services. Its 8-K reports disclose operating results, financial outlook updates, Regulation FD information, material agreements involving Conifer, and debt financing matters tied to senior secured first lien notes and senior notes.
Tenet's proxy and current reports also cover board composition, shareholder voting matters, executive compensation, officer transition agreements, controller and principal accounting officer appointments, equity-award terms, common stock, senior-note securities and related governance disclosures. These filings connect THC's capital structure and management oversight to its Ambulatory, Hospital and Conifer business activities.
Tenet Healthcare Corporation reported the results of its 2026 Annual Meeting of Shareholders held on May 27, 2026. Shareholders elected all nominated directors to the Board, with each receiving more than 71 million votes in favor and relatively few votes against or abstentions.
Shareholders also approved, on an advisory basis, the Company’s executive compensation, with 62,554,346 votes for and 11,817,273 against, plus a small number of abstentions and broker non-votes. In addition, shareholders ratified the selection of Deloitte & Touche LLP as the independent registered public accountants for the year ending December 31, 2026, with 79,422,386 votes in favor and minimal opposition.
Agarwala Vineeta reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare Corp director Vineeta Agarwala received a grant of 1,188 restricted stock units. These 2026 May Restricted Stock Units were awarded at no cost and are each economically equivalent to one share of Tenet’s common stock.
The units vest on the first anniversary of the grant date, aligning Agarwala’s compensation with the company’s future performance. After this grant, she holds 1,188 restricted stock units directly. She may elect to receive up to 37% of the vested units in cash instead of shares.
Blunt Roy reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Roy Blunt received a grant of 1,188 restricted stock units as compensation. These 2026 May Restricted Stock Units were awarded at a price of $0.00 per unit and are economically equivalent to 1,188 shares of Tenet common stock.
The units vest on the first anniversary of the grant date, so they are scheduled to vest on May 27, 2027, if service-based conditions are met. After this grant, Blunt holds 1,188 restricted stock units directly. He may elect to receive up to 37% of these vested units in cash instead of shares, which gives some flexibility in how the award is settled.
MARK RICHARD J reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Richard J. Mark received a grant of 1,188 restricted stock units. The 2026 May RSUs were awarded at no cost and are equivalent to 1,188 shares of common stock. They vest on the first anniversary of the grant, and up to 37% may be settled in cash instead of shares.
TENET HEALTHCARE CORP director Nadja West reported mixed insider activity. She completed an open-market sale of 3,000 shares of Common Stock at $177.35 per share and now directly holds 24,805 shares. She was also granted 1,188 restricted stock units that vest on the first anniversary of the grant, each equivalent to one common share, with an option to receive up to 37% of these units in cash.
Tenet Healthcare director Richard W. Fisher received a new equity award in the form of restricted stock units. On May 27, 2026, he was granted 1,188 2026 May Restricted Stock Units, each economically equivalent to one share of Tenet’s common stock.
The award was granted under the company’s Stock Incentive Plan at no exercise price and will vest on the first anniversary of the grant date. After this grant, Fisher holds 1,188 restricted stock units directly, and he may elect to receive up to 37% of these units in cash instead of shares at settlement.
HANEY CECIL D reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare director Cecil D. Haney received a grant of 1,188 restricted stock units as equity compensation. The units were granted at no cash cost and are tied to the company’s common stock on a one-for-one basis. These restricted stock units vest on the first anniversary of the grant date, aligning the director’s compensation with long-term performance. After this award, Haney holds 1,188 restricted stock units directly, and may elect to receive up to 37% of them in cash instead of shares at settlement.
BIERMAN JAMES L reported acquisition or exercise transactions in this Form 4 filing.
Tenet Healthcare Corp director James L. Bierman reported an award of 1,188 restricted stock units tied to the company’s common stock. The units were granted at no cost and are the economic equivalent of 1,188 shares of common stock. These restricted stock units vest on the first anniversary of the grant date. Bierman may elect to receive up to 37% of the vested units in cash instead of shares, with the remainder settled in stock.
Romo Tammy reported acquisition or exercise transactions in this Form 4 filing.
Tammy Romo, a director of Tenet Healthcare, received a grant of 1,188 restricted stock units under the company’s Stock Incentive Plan. Each unit is the economic equivalent of one common share.
The units vest on the first anniversary of the grant, and she may elect to receive up to 37% of them in cash instead of shares, leaving her reported derivative holdings at 1,188 units.
Tenet Healthcare director Christopher S. Lynch received a grant of 1,188 restricted stock units tied to common stock. These 2026 May Restricted Stock Units were awarded at no exercise price and are structured as equity-based compensation.
The units vest on the first anniversary of the grant date, 27 May 2027, meaning Lynch must remain eligible through that date to receive the shares or cash. Each unit is the economic equivalent of one share of Tenet’s common stock, and Lynch may elect to receive up to 37% of the vested units in cash instead of shares.